scholarly article | Q13442814 |
P50 | author | Lena Eliasson | Q38323396 |
Jonathan Lou S Esguerra | Q57320830 | ||
P2093 | author name string | J L S Esguerra | |
P2860 | cites work | High glucose suppresses human islet insulin biosynthesis by inducing miR-133a leading to decreased polypyrimidine tract binding protein-expression | Q21136357 |
Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development | Q21145874 | ||
An integrated encyclopedia of DNA elements in the human genome | Q22122150 | ||
The unique cytoarchitecture of human pancreatic islets has implications for islet cell function | Q24541464 | ||
Bidirectional integrative regulation of Cav1.2 calcium channel by microRNA miR-103: role in pain | Q24594587 | ||
The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression | Q24608592 | ||
MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
lncRNAdb: a reference database for long noncoding RNAs | Q24612233 | ||
miR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells | Q24645027 | ||
Specific expression of long noncoding RNAs in the mouse brain | Q24648944 | ||
Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation | Q24655701 | ||
miR-375 maintains normal pancreatic alpha- and beta-cell mass | Q24657284 | ||
Differential glucose-regulation of microRNAs in pancreatic islets of non-obese type 2 diabetes model Goto-Kakizaki rat | Q27347966 | ||
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 | Q27860849 | ||
Silencing of microRNAs in vivo with 'antagomirs' | Q27860891 | ||
MicroRNAs: small RNAs with a big role in gene regulation | Q27860896 | ||
Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients | Q27863911 | ||
MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells | Q28251177 | ||
A pancreatic islet-specific microRNA regulates insulin secretion | Q28292726 | ||
MicroRNA expression is required for pancreatic islet cell genesis in the mouse | Q28585393 | ||
Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses | Q29547647 | ||
Treatment of HCV infection by targeting microRNA | Q29547712 | ||
Long noncoding RNAs with enhancer-like function in human cells | Q29614328 | ||
Argonaute proteins: key players in RNA silencing | Q29614714 | ||
Long noncoding RNAs: functional surprises from the RNA world | Q29615826 | ||
Molecular mechanisms of long noncoding RNAs | Q29618027 | ||
Non-coding RNAs: regulators of disease | Q29618040 | ||
Argonaute2 mediates compensatory expansion of the pancreatic β cell | Q30414353 | ||
Human β cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes | Q30416868 | ||
Epigenomic plasticity enables human pancreatic α to β cell reprogramming. | Q30536573 | ||
Identification of the docked granule pool responsible for the first phase of glucose-stimulated insulin secretion. | Q33178866 | ||
Identification and characterization of small RNAs involved in RNA silencing | Q33223084 | ||
MicroRNA-7a regulates pancreatic β cell function | Q33685948 | ||
Specialized ribosomes: a new frontier in gene regulation and organismal biology | Q33689623 | ||
Overexpression of monocarboxylate transporter and lactate dehydrogenase alters insulin secretory responses to pyruvate and lactate in beta cells | Q33902405 | ||
The reality of pervasive transcription | Q33963677 | ||
PIWI proteins and PIWI-interacting RNAs in the soma | Q34039572 | ||
Beta-cell specific deletion of Dicer1 leads to defective insulin secretion and diabetes mellitus. | Q34117281 | ||
MicroRNA-7 regulates the mTOR pathway and proliferation in adult pancreatic β-cells | Q34316436 | ||
LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA. | Q34359833 | ||
Topological organization of multichromosomal regions by the long intergenic noncoding RNA Firre | Q34400074 | ||
genenames.org: the HGNC resources in 2011. | Q34456662 | ||
Cell-type-specific signatures of microRNAs on target mRNA expression | Q34479693 | ||
The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis | Q34571691 | ||
Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription | Q34908066 | ||
Glucose-stimulated signaling pathways in biphasic insulin secretion | Q35018519 | ||
Genome-wide DNA methylation analysis of human pancreatic islets from type 2 diabetic and non-diabetic donors identifies candidate genes that influence insulin secretion | Q35112943 | ||
Insulin granule dynamics in pancreatic beta cells | Q35184211 | ||
L-leucine alters pancreatic β-cell differentiation and function via the mTor signaling pathway | Q35696480 | ||
Reduced insulin exocytosis in human pancreatic β-cells with gene variants linked to type 2 diabetes | Q36047543 | ||
Changes in microRNA expression contribute to pancreatic β-cell dysfunction in prediabetic NOD mice | Q36047577 | ||
MicroRNA-30d induces insulin transcription factor MafA and insulin production by targeting mitogen-activated protein 4 kinase 4 (MAP4K4) in pancreatic β-cells | Q36225727 | ||
MicroRNAs contribute to compensatory β cell expansion during pregnancy and obesity | Q36290327 | ||
Non-invasive in vivo imaging of pancreatic β-cell function and survival - a perspective | Q36485583 | ||
Functional importance of individual rRNA 2'-O-ribose methylations revealed by high-resolution phenotyping | Q36503772 | ||
Islet β cell mass in diabetes and how it relates to function, birth, and death | Q36745536 | ||
Matched miRNA and mRNA signatures from an hESC-based in vitro model of pancreatic differentiation reveal novel regulatory interactions. | Q37132484 | ||
mTORC1 activation regulates beta-cell mass and proliferation by modulation of cyclin D2 synthesis and stability | Q37134416 | ||
Novel aspects of the molecular mechanisms controlling insulin secretion | Q37176911 | ||
Thioredoxin-interacting protein regulates insulin transcription through microRNA-204 | Q37330393 | ||
Tight coupling between glucose and mitochondrial metabolism in clonal beta-cells is required for robust insulin secretion | Q37431971 | ||
Epigenetic regulation of the DLK1-MEG3 microRNA cluster in human type 2 diabetic islets. | Q37599098 | ||
Genetic basis of beta-cell dysfunction in man. | Q37611949 | ||
ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. | Q37801219 | ||
Diabetes mellitus, a microRNA-related disease? | Q37855088 | ||
The exocytotic machinery | Q38179061 | ||
A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion | Q38271856 | ||
Syntaxin-1a is a direct target of miR-29a in insulin-producing β-cells. | Q39211230 | ||
MicroRNA-29a is up-regulated in beta-cells by glucose and decreases glucose-stimulated insulin secretion | Q39287052 | ||
Functional subdivision of islets of Langerhans and possible role of D cells | Q39356963 | ||
MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression | Q39621720 | ||
Functional specificity among ribosomal proteins regulates gene expression | Q39666047 | ||
Munc 18-1 and granuphilin collaborate during insulin granule exocytosis | Q40022400 | ||
Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs | Q40028213 | ||
MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation | Q40036365 | ||
Modulation of glutamate generation in mitochondria affects hormone secretion in INS-1E beta cells | Q40841075 | ||
Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion | Q40871524 | ||
Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms | Q41729392 | ||
miRNAs control insulin content in pancreatic β-cells via downregulation of transcriptional repressors. | Q41899866 | ||
MicroRNAs are essential for stretch-induced vascular smooth muscle contractile differentiation via microRNA (miR)-145-dependent expression of L-type calcium channels | Q42183020 | ||
Glucose-stimulated DNA synthesis through mammalian target of rapamycin (mTOR) is regulated by KATP channels: effects on cell cycle progression in rodent islets | Q42487818 | ||
The human L-type calcium channel Cav1.3 regulates insulin release and polymorphisms in CACNA1D associate with type 2 diabetes | Q43586741 | ||
Reduced insulin secretion correlates with decreased expression of exocytotic genes in pancreatic islets from patients with type 2 diabetes. | Q45904927 | ||
MicroRNAs and Cellular Phenotypy | Q46084261 | ||
The relationship between non-protein-coding DNA and eukaryotic complexity. | Q51994672 | ||
P433 | issue | 2 | |
P921 | main subject | physiology | Q521 |
P304 | page(s) | 273-284 | |
P577 | publication date | 2014-04-15 | |
P1433 | published in | Acta Physiologica | Q2662816 |
P1476 | title | Role of non-coding RNAs in pancreatic beta-cell development and physiology | |
P478 | volume | 211 |
Q39659496 | A Systematic Comparison of Purification and Normalization Protocols for Quantitative MicroRNA Expressional Profiling in Insulin-Producing Cells |
Q37728970 | A Systematic Study of Dysregulated MicroRNA in Type 2 Diabetes Mellitus |
Q38727328 | Beyond the Protein-Coding Sequence: Noncoding RNAs in the Pathogenesis of Type 2 Diabetes |
Q40989248 | Confluence does not affect the expression of miR-375 and its direct targets in rat and human insulin-secreting cell lines. |
Q33631728 | Contribution of Intronic miR-338-3p and Its Hosting Gene AATK to Compensatory β-Cell Mass Expansion |
Q35741902 | Cross-talks between microRNAs and mRNAs in pancreatic tissues of streptozotocin-induced type 1 diabetic mice |
Q36427543 | Disease, Models, Variants and Altered Pathways-Journeying RGD Through the Magnifying Glass |
Q38711086 | Elevated miR-130a/miR130b/miR-152 expression reduces intracellular ATP levels in the pancreatic beta cell |
Q47843069 | Exosomes as new players in metabolic organ cross-talk |
Q38234967 | Functional implications of long non-coding RNAs in the pancreatic islets of Langerhans. |
Q38590582 | Genes affecting β-cell function in type 1 diabetes |
Q35212277 | Horizontal transfer of exosomal microRNAs transduce apoptotic signals between pancreatic beta-cells |
Q60191798 | Lessons from basic pancreatic beta cell research in type-2 diabetes and vascular complications |
Q48128285 | Lnc-ing non-coding RNAs with metabolism and diabetes: roles of lncRNAs. |
Q39454814 | Long non-coding RNAs as novel players in β cell function and type 1 diabetes |
Q48035493 | Loss of the imprinted, non-coding Snord116 gene cluster in the interval deleted in the Prader Willi syndrome results in murine neuronal and endocrine pancreatic developmental phenotypes |
Q45424255 | MiR-335 overexpression impairs insulin secretion through defective priming of insulin vesicles. |
Q55001944 | MicroRNA Expression Analysis of In Vitro Dedifferentiated Human Pancreatic Islet Cells Reveals the Activation of the Pluripotency-Related MicroRNA Cluster miR-302s. |
Q38438584 | MicroRNA expression profiles of human iPSCs differentiation into insulin-producing cells. |
Q54959769 | MicroRNA, Proteins, and Metabolites as Novel Biomarkers for Prediabetes, Diabetes, and Related Complications. |
Q39030840 | MicroRNAs as paracrine signaling mediators in cancers and metabolic diseases |
Q40031615 | Modulation of microRNA-375 expression alters voltage-gated Na(+) channel properties and exocytosis in insulin-secreting cells |
Q60957230 | Non-Coding RNA in Pancreas and β-Cell Development |
Q38360373 | Noncoding RNAs in β cell biology |
Q38677224 | PIWI-interacting RNAs as novel regulators of pancreatic beta cell function |
Q57793580 | Pancreatic Neuroendocrine Tumor Producing Insulin and Vasopressin |
Q38429701 | Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes |
Q47565462 | RNA interference-based therapy and its delivery systems |
Q38266502 | Regulation of Pancreatic Beta Cell Stimulus-Secretion Coupling by microRNAs. |
Q38289805 | Role of islet microRNAs in diabetes: which model for which question? |
Q38951145 | Role of long non-coding RNAs in the determination of β-cell identity |
Q52657734 | The Cells of the Islets of Langerhans. |
Q58588238 | miR-483-5p associates with obesity and insulin resistance and independently associates with new onset diabetes mellitus and cardiovascular disease |
Q45738598 | miRNome Profiling of Purified Endoderm and Mesoderm Differentiated from hESCs Reveals Functions of miR-483-3p and miR-1263 for Cell-Fate Decisions |
Search more.